Consistent with these observations, the TRAMP PCa mouse model showed a reduction in TXNIP at both RNA and protein level during tumor progression when compared with their WT counterparts at 32 and 44 weeks (Figs. 1F–I, and S1A). This evidence concerns the gene TXNIP and posterior cortical atrophy.